University of Kentucky Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening
OphthalmologyDiabetic Eye Disease in Primary Care
May 03, 2019
The accreditation for this activity has expired.
Primary Audience:
This activity is intended for primary care clinicians and allied health providers who treat patients with type 2 diabetes.
Relevant Terms:
Diabetic retinopathy; diabetic macular edema
Ana Bastos de Carvalho, MD
Ana Bastos de Carvalho, MD
Bio
Ana Bastos de Carvalho, MD, is a full-time instructor at the Department of Ophthalmology & Visual Sciences at the University of Kentucky. She is a medical retina fellow and the co-director of the Global Ophthalmology Division. She also works with Dr. Eric Higgins to optimize and expand the department’s teleretinal screening network, comprising 45 sites state-wide where diabetic retinopathy screening is provided.
Dr. Carvalho attended medical school and completed an ophthalmology residency at the Lisbon Medical School, in Lisbon, Portugal. In 2011, she joined the Department of Ophthalmology at the University of Kentucky to conduct post-doctoral research in age-related macular degeneration. She subsequently joined the clinical faculty at the department in 2017 to complete a medical retina fellowship.
Dr. Carvalho is actively involved in research, mainly focusing on implementation of screening for retinal diseases, and has contributed numerous original papers in peer-reviewed journals.
| 1. | Utilize available retinal screening devices as part of regular screening of all patients with diabetes according to the newest American Diabetes Association (ADA)/American Academy of Ophthalmology (AAO) guidelines. | 2. | Consider the importance of early screening and treatment relative to the pathophysiology of DR and DME. |
| 3. | Evaluate differences among current and emerging therapies for DR and DME and work collaboratively with retina specialists to develop treatment plans based upon efficacy and shared-decision making. |
| 1. | Utilize available retinal screening devices as part of regular screening of all patients with diabetes according to the newest American Diabetes Association (ADA)/American Academy of Ophthalmology (AAO) guidelines. |
| 2. | Consider the importance of early screening and treatment relative to the pathophysiology of DR and DME. |
| 3. | Evaluate differences among current and emerging therapies for DR and DME and work collaboratively with retina specialists to develop treatment plans based upon efficacy and shared-decision making. |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine and DKBmed. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Kentucky College of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
ACME Competencies
- Medical Knowledge
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the University of Kentucky, and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other
UK Healthcare CECentral certifies this activity for 1.0 hours of participation.
Disclosure of Conflicts of Interest
Planners and Managers
Planning committee members from the University of Kentucky, Roberto Cardarelli, DO, MPH, FAAFP; Rob Sprang, MBA; and Eric Higgins, MD have nothing to disclose.
The PIM planners and managers have nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Internet
| Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
© 2007-2024 HealthCourse, Inc. All rights reserved.
